Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Lutetium texaphyrin"'
Publikováno v:
Scopus-Elsevier
Lutetium (III) texaphyrin photosensitizes postirradiation or "delayed" photohemolysis (DPH) of human and bovine red blood cells at 730 nm by a Type-2 pathway mediated by singlet molecular oxygen. The DPH rate increases with increasing incubation temp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c8159b147e4131e6620942999113792
https://doi.org/10.1562/0031-8655(2000)0720121porbch2.0.co2
https://doi.org/10.1562/0031-8655(2000)0720121porbch2.0.co2
Autor:
Jennifer I. Lim
Publikováno v:
Ophthalmology Clinics of North America. 15:473-478
Photodynamic therapy with visudyne for choroidal neovascular disease (CNV) has proved effective at preventing moderate to severe visual loss in eyes with subfoveal predominantly classic CNV or occult-only CNV caused by age-related macular degeneratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef8fcc634e21d4c6cc53494eb7a88a4e
https://doi.org/10.1016/s0896-1549(02)00044-5
https://doi.org/10.1016/s0896-1549(02)00044-5
Publikováno v:
Lasers in Surgery and Medicine. 24:276-284
Background and Objective New photosensitizers proposed for photodynamic therapy (PDT) treatment of tumors need to be evaluated in animal models to determine the parameters needed for treatment. They also need to be compared with existing photosensiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0171242ba08014bd84bad5723223e69
https://doi.org/10.1002/(sici)1096-9101(1999)24:4<276::aid-lsm5>3.0.co
https://doi.org/10.1002/(sici)1096-9101(1999)24:4<276::aid-lsm5>3.0.co
Publikováno v:
Biomedical Optics.
Spectrally-constrained diffuse tomography is used to image endogenous and exogenous tissue chromophore concentrations with higher accuracy than when using individual wavelengths. Reconstructed images from simulated data demonstrate that concentration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d991b537e206afb01d915dc52f585d73
https://doi.org/10.1364/bio.2006.sh36
https://doi.org/10.1364/bio.2006.sh36
Publikováno v:
Proceedings of the 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (Cat. No.00CH37143).
Presents a simple method to quantitatively estimate the concentration of photodynamic therapy (PDT) photosensitizer Lutetium texaphyrin (Lutrin (R)) in vivo. The technique is relative and does not require difficult absolute measurements of fluorescen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::262f5e00776713f7c61f0cb4da407261
https://doi.org/10.1109/iembs.2000.900864
https://doi.org/10.1109/iembs.2000.900864
Autor:
Stanley G. Rockson
Publikováno v:
Current treatment options in cardiovascular medicine. 1(3)
Photoangioplasty with ANTRIN™ represents a novel therapeutic application in human atherosclerosis. The biology of the response to photoangioplasty allows it to hold great promise as an approach to minimizing structural damage to the blood vessel at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a172a11721faef021720ec104753cc1
https://pubmed.ncbi.nlm.nih.gov/11096484
https://pubmed.ncbi.nlm.nih.gov/11096484
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kathryn W. Woodburn, Patricia Thiemann
Publikováno v:
SPIE Proceedings.
Lutetium texaphyrin (Lu-Tex) photodynamic therapy (PDT) relies on the presence of the water-soluble Lu-Tex, oxygen, and light (activation around 730 nm). Cytotoxic oxygen species are produced that cause irreversible damage to biological substrates. D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf96766b873163c9fe948b10407b3745
https://doi.org/10.1117/12.308131
https://doi.org/10.1117/12.308131
Publikováno v:
SPIE Proceedings.
Cardiovascular disease is the chief cause of death in the western world. Lutetium texaphyrin (PCI-0123) is a pure, synthetic, aqueous-soluble macrocycle that localizes in both cancerous lesions and atheromatous plaque. The lutetium texaphyrin complex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28229631fd6543368c025f4d01c83028
https://doi.org/10.1117/12.275065
https://doi.org/10.1117/12.275065
Publikováno v:
SPIE Proceedings.
Lutetium texaphyrin (PCI-0123) is currently in clinical trials as a PDT agent for the treatment of cancer patients. The drug is cleared rapidly from the plasma, and photoirradiation can be performed shortly after drug administration.T He photosensiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::810558ba432016aa59824d4d366706ae
https://doi.org/10.1117/12.273485
https://doi.org/10.1117/12.273485